The lesion, originally diagnosed as pyoderma gangrenosum, now measures 15 cm × 6 cm. What should be the next step in management?
Disease-modifying therapies have been a big advance in multiple sclerosis, but many patients still experience a variety of symptoms that reduce quality of life. We have to treat the whole patient.